Key result
Radiofrequency ablation terminates drug-refractory fascicular VT in an infant, normalizing LVEF without recurrence at 2 years.
Why the study?
Does radiofrequency ablation improve clinical status in an infant with drug-refractory incessant fascicular ventricular tachycardia and heart failure?
Case Report (n=1)
No
Does radiofrequency ablation improve clinical status in an infant with drug-refractory incessant fascicular ventricular tachycardia and heart failure?
Radiofrequency ablation can successfully restore sinus rhythm and improve cardiac function in infants with drug-refractory incessant fascicular ventricular tachycardia.
Answers are grounded in this paper and cite their sources.
May warrant consideration in refractory infant cases; leaves open need for prospective data before broader adoption.
We report an eight month old infant who presented with incessant Fascicular tachycardia and heart failure which was refractory to drugs and cardioversion. Sinus rhythm was restored by radio frequency ablation and this resulted in improvement in clinical status and cardiac function. Role of catheter ablation in this situation is discussed.
No takes yet. Share an insight, caveat, or question.
Verma et al. (2020) conducted a case report in Incessant fascicular ventricular tachycardia and heart failure (n=1). Radiofrequency ablation was evaluated on Termination of ventricular tachycardia and reversal of left ventricular function. Radiofrequency ablation successfully terminated incessant drug-refractory fascicular ventricular tachycardia in an 8-month-old infant, leading to normalization of left ventricular ejection fraction with no recurrence at 2 years.
Synapse has enriched 10 related papers. Consider them for comparative context: